385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Terbinafine 1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Osmanil 50micrograms/hour transdermal patches (Zentiva Pharma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Osmanil 25micrograms/hour transdermal patches (Zentiva Pharma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Osmanil 75micrograms/hour transdermal patches (Zentiva Pharma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Osmanil 100micrograms/hour transdermal patches (Zentiva Pharma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Victanyl 100micrograms/hour transdermal patches (Accord Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Victanyl 75micrograms/hour transdermal patches (Accord Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Victanyl 25micrograms/hour transdermal patches (Accord Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Victanyl 50micrograms/hour transdermal patches (Accord Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
NiQuitin Clear 14mg patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicorette 10mg patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicorette 15mg patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
NiQuitin Clear 21mg patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicorette 5mg patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Deponit 10 transdermal patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% cream (Actavis UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoyl peroxide 5% gel (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% ointment (Actavis UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Deponit 5 transdermal patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoyl peroxide 10% gel (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone + Potassium hydroxyquinolone sulphate	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Canesten Antifungal 1% cream (Bayer Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betacap 0.1% scalp application (Dermal Laboratories Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eurax lotion (Novartis Consumer Health UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Occlusal 26% solution (Alliance Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zineryt lotion (Neon Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Trosyl 28.3% nail solution (Pfizer Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Elocon 0.1% scalp lotion (Organon Pharma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Stiemycin 2% solution (Stiefel Laboratories Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betadine 2.5% dry powder spray (Medlock Medical)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Traxam 3.17% foam (Goldshield Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Quellada-M 0.5% liquid (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Exorex 1% lotion (Forest Laboratories UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuspray 5% spray (Dermal Laboratories Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Anhydrol Forte 20% solution (Dermal Laboratories Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Silkis ointment (Galderma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Driclor 20% solution (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Prioderm 0.5% lotion (SSL International Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Derbac-M 0.5% liquid (SSL International Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuleve 5% spray (Dendron Brands Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Loceryl 5% nail lacquer (Galderma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Suleo-M 0.5% lotion (SSL International Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betnovate 0.1% scalp application (GlaxoSmithKline)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dalacin T 1% topical solution (Pfizer Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dalacin T 1% topical lotion (Pfizer Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dovonex 50micrograms/ml scalp solution (LEO Pharma)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Full Marks 0.2% lotion (SSL International Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Full Marks 0.5% liquid (SSL International Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Balmosa cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Capasal Therapeutic shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Ceanel Concentrate shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Cocois ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Covermark classic foundation	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Covermark finishing powder	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Dermablend cover creme	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Dermablend leg & body cover	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Dermablend setting powder	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Dermacolor camouflage creme	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Dermacolor fixing powder	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lyclear 1% creme rinse (Pfizer Consumer Healthcare)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hibiscrub 4% solution (Regent Medical Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrex 4% Surgical Scrub (Adams Healthcare)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Dermovate-NN cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Dermovate-NN ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 20micrograms/24hours patches	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol valerate 2mg / Levonorgestrel 75microgram tablets	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol valerate 1mg / Levonorgestrel 250microgram tablets	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Veil cover cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Veil finishing powder translucent	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Keromask finishing powder translucent	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Keromask masking cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Nystaform HC cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Otomize ear spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Polytar AF liquid	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Polytar liquid	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Transvasin Heat Rub cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Tri-Adcortyl Otic ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Tri-Adcortyl cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Tri-Adcortyl ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Topicycline 2.2mg/ml topical solution (Shire Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Canesten 1% solution (Bayer Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Full Marks 0.5% mousse (SSL International Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlortetracycline 3.09% / Triamcinolone acetonide 0.1% ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Canesten Dermatological 1% spray (Bayer Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Canesten AF 1% spray (Bayer Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eucerin Extremely Dry Skin Treatment 10% lotion (Beiersdorf UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ametop 4% gel (Smith & Nephew Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cetrimide 0.5% / Chlorhexidine gluconate 0.1% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
PanOxyl 5 lotion (Stiefel Laboratories Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Oxy 5 lotion (GlaxoSmithKline Consumer Healthcare)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoin compound tincture (Thornton & Ross Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoin compound tincture (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
PanOxyl 10 wash (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoin compound tincture (J M Loveridge Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betnovate 0.1% lotion (GlaxoSmithKline)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 41 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module